|
|
|
| |
|
CommentsAdvance toward an imaging agent for diagnosing Alzheimer’s diseasePosted by American Chemical Society on Apr 4, 2012 at 02:21 PM
The scientists describe the synthesis and lab testing of a new imaging agent (called FPPDB), ACS Medicinal Chemistry Letters Scientists are reporting development and initial laboratory tests of an imaging agent that shows promise for detecting the tell-tale signs of Alzheimer’s disease (AD) in the brain — signs that now can’t confirm a diagnosis until after patients have died. Their report appears in the journal ACS Medicinal Chemistry Letters. More...Post a Comment on: Advance toward an imaging agent for diagnosing Alzheimer’s diseaseCommenting is not available in this channel entry. Next entries comments: Greening up the blue dye in jeans, police uniforms and the red, white & blue Previous entries comments: Carbon nanotubes can double growth of cell cultures important in industry Note from the Editor: This section is for comments from readers of canadafreepress.com. Please don't assume that Canada Free Press agrees with or endorses any particular comment just because we let it stand. A reminder: Anyone who fails to comply with our terms of use may lose his or her posting privilege. |
|
